Literature DB >> 24297765

Effectiveness of papaverine cisternal irrigation for cerebral vasospasm after aneurysmal subarachnoid hemorrhage and measurement of biomarkers.

Jae Hoon Kim1, Hyeong-Joong Yi, Yong Ko, Young-Soo Kim, Dong-Won Kim, Jae-Min Kim.   

Abstract

Cisternal irrigation with thrombolytic agents was used to prevent post-SAH vasospasm, but its role remained inconclusive. To verify effectiveness of papaverine (PPV) in preventing vasospasm, we studied relationship between inflammatory biologic markers and vasospasm. This prospective study included 121 patients with clipped anterior circulation aneurysms that had ruptured, and 372 control patients. Patients were divided into three groups according to cisternal irrigation method: simple drain, papaverine group, and urokinase (UK) group. Intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) were determined in CSF and serum on days 3 and 7 after SAH. The PPV group showed similar incidence of vasospasm with UK group, but lower incidence than the simple drain group. The levels of ICAM-1 and VCAM-1 were significantly higher in the SAH group than in the control group. CSF and serum levels were more elevated on day 7 than day 3, and the degree of elevation were more marked when measured in the CSF than in the serum. However, there was no statistical difference between measured levels of ICAM-1 and VCAM-1, and vasospasm development. PPV cisternal irrigation was similarly effective as UK at preventing vasospasm. Although neither PPV nor UK irrigation could reduce the concentration of adhesion molecules compared with simple drain, we found levels of ICAM-1 and VCAM-1 were specifically elevated in the CSF. Therefore, further research should focus on anti-inflammation as a therapeutic target against cerebral vasospasm and on the CSF as the optimum place where such inflammatory action practically brought about.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24297765     DOI: 10.1007/s10072-013-1589-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  26 in total

1.  Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a study of urokinase concentration and the fibrinolytic system.

Authors:  T Sasaki; N Kodama; M Kawakami; M Sato; J Asari; Y Sakurai; K Watanabe; T Onuma; T Matsuda
Journal:  Stroke       Date:  2000-06       Impact factor: 7.914

2.  Detection of soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage.

Authors:  Mehmet Yasar Kaynar; Taner Tanriverdi; Ali Metin Kafadar; Tibet Kacira; Hafize Uzun; Seval Aydin; Koray Gumustas; Ahmet Dirican; Cengiz Kuday
Journal:  J Neurosurg       Date:  2004-12       Impact factor: 5.115

3.  Haemodynamic changes after intracisternal papaverine instillation during intracranial aneurysmal surgery.

Authors:  G P Rath; H Prabhakar; H H Dash; A Suri
Journal:  Br J Anaesth       Date:  2006-09-19       Impact factor: 9.166

4.  Prophylactic effect of papaverine prolonged-release pellets on cerebral vasospasm in dogs.

Authors:  K Shiokawa; H Kasuya; M Miyajima; M Izawa; K Takakura
Journal:  Neurosurgery       Date:  1998-01       Impact factor: 4.654

5.  Rabbit vascular endothelial adhesion molecules: ELAM-1 is most elevated in acute inflammation, whereas VCAM-1 and ICAM-1 predominate in chronic inflammation.

Authors:  Y Abe; K Sugisaki; A M Dannenberg
Journal:  J Leukoc Biol       Date:  1996-12       Impact factor: 4.962

6.  A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  T Sasaki; T Ohta; H Kikuchi; K Takakura; M Usui; H Ohnishi; A Kondo; H Tanabe; J Nakamura; K Yamada
Journal:  Neurosurgery       Date:  1994-10       Impact factor: 4.654

7.  Is vascular angiopathy following intracranial aneurysm rupture immunologically mediated?

Authors:  M Ryba; M Jarzabek-Chorzelska; T Chorzelski; M Pastuszko
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

8.  Disruption of the blood-brain barrier by intra-arterial administration of papaverine: a technical note.

Authors:  Johannes Platz; Krisztina Baráth; Emanuela Keller; Anton Valavanis
Journal:  Neuroradiology       Date:  2008-09-13       Impact factor: 2.804

9.  Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients.

Authors:  N Kodama; T Sasaki; M Kawakami; M Sato; J Asari
Journal:  Surg Neurol       Date:  2000-02

10.  Enhanced cisternal drainage and cerebral vasospasm in early aneurysm surgery.

Authors:  U Ito; H Tomita; S Yamazaki; Y Takada; Y Inaba
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

View more
  6 in total

Review 1.  Delayed cerebral ischaemia prevention and treatment after aneurysmal subarachnoid haemorrhage: a systematic review.

Authors:  M Veldeman; A Höllig; H Clusmann; A Stevanovic; R Rossaint; M Coburn
Journal:  Br J Anaesth       Date:  2016-05-08       Impact factor: 9.166

2.  Delayed morbidity and mortality in aneurysmal subarachnoid hemorrhage patients: effect of attenuating cerebral vasospasm.

Authors:  Dale Ding
Journal:  Neurol Sci       Date:  2014-07-01       Impact factor: 3.307

Review 3.  Treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis.

Authors:  Grégoire Boulouis; Marc Antoine Labeyrie; Jean Raymond; Christine Rodriguez-Régent; Anne Claire Lukaszewicz; Damien Bresson; Wagih Ben Hassen; Denis Trystram; Jean Francois Meder; Catherine Oppenheim; Olivier Naggara
Journal:  Eur Radiol       Date:  2016-12-21       Impact factor: 5.315

4.  Papaverine inhibits lipopolysaccharide-induced microglial activation by suppressing NF-κB signaling pathway.

Authors:  Yalong Dang; Yalin Mu; Kun Wang; Ke Xu; Jing Yang; Yu Zhu; Bin Luo
Journal:  Drug Des Devel Ther       Date:  2016-02-26       Impact factor: 4.162

5.  The phosphodiesterase 10 inhibitor papaverine exerts anti-inflammatory and neuroprotective effects via the PKA signaling pathway in neuroinflammation and Parkinson's disease mouse models.

Authors:  Yu-Young Lee; Jin-Sun Park; Yea-Hyun Leem; Jung-Eun Park; Do-Yeon Kim; Youn-Hee Choi; Eun-Mi Park; Jihee Lee Kang; Hee-Sun Kim
Journal:  J Neuroinflammation       Date:  2019-12-02       Impact factor: 8.322

Review 6.  Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage.

Authors:  Brandon A Miller; Nefize Turan; Monica Chau; Gustavo Pradilla
Journal:  Biomed Res Int       Date:  2014-07-03       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.